Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibiotics in Crohn's disease.

Literature DB >> 11302962

Antibiotics in Crohn's disease.

J F Colombel¹, A Cortot, H J van Kruiningen.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2001 PMID： 11302962 PMCID： PMC1728297 DOI： 10.1136/gut.48.5.647

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

8 in total

1. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors: C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal: Inflamm Bowel Dis Date: 2000-02 Impact factor: 5.325

Review 2. Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.

Authors: K Hultén; A Almashhrawi; F A El-Zaatari; D Y Graham
Journal: Dig Dis Sci Date: 2000-03 Impact factor: 3.199

3. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

Authors: J F Colombel; M Lémann; M Cassagnou; Y Bouhnik; B Duclos; J L Dupas; B Notteghem; J Y Mary
Journal: Am J Gastroenterol Date: 1999-03 Impact factor: 10.864

4. Open label trial of oral clarithromycin in active Crohn's disease.

Authors: K Leiper; A I Morris; J M Rhodes
Journal: Aliment Pharmacol Ther Date: 2000-06 Impact factor: 8.171

5. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

Authors: A Darfeuille-Michaud; C Neut; N Barnich; E Lederman; P Di Martino; P Desreumaux; L Gambiez; B Joly; A Cortot; J F Colombel
Journal: Gastroenterology Date: 1998-12 Impact factor: 22.682

Review 6. On the use of antibiotics in Crohn's disease.

Authors: H J Van Kruiningen
Journal: J Clin Gastroenterol Date: 1995-06 Impact factor: 3.062

7. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.

Authors: C Prantera; F Zannoni; M L Scribano; E Berto; A Andreoli; A Kohn; C Luzi
Journal: Am J Gastroenterol Date: 1996-02 Impact factor: 10.864

8. Healing of perineal Crohn's disease with metronidazole.

Authors: L H Bernstein; M S Frank; L J Brandt; S J Boley
Journal: Gastroenterology Date: 1980-08 Impact factor: 22.682

8 in total

7 in total

Review 7. Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer.

Authors: John Gubatan; Theresa Louise Boye; Michelle Temby; Raoul S Sojwal; Derek R Holman; Sidhartha R Sinha; Stephan R Rogalla; Ole Haagen Nielsen
Journal: Microorganisms Date: 2022-07-07

7 in total

Antibiotics in Crohn's disease.

1. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Review 2. Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.

3. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

4. Open label trial of oral clarithromycin in active Crohn's disease.

5. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

Review 6. On the use of antibiotics in Crohn's disease.

7. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.

8. Healing of perineal Crohn's disease with metronidazole.

Review 1. Role of the innate immune system in the development of chronic colitis.

2. Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.

3. The Current Use of Antibiotic Therapies for IBD.

4. The role of bacteria in the pathogenesis of inflammatory bowel disease.

Review 5. Use of the tumor necrosis factor-blockers for Crohn's disease.

6. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.

Review 7. Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer.